Canine Histiocytic Sarcoma: Breeds at Risk, Treatment, Costs, and Clinical Trials in 2026
By Brycen Levings | Editor: Tariq Shah · August 26, 2026
An Aggressive Cancer With a Breed Signature
Histiocytic sarcoma is an aggressive cancer of the immune system's histiocytes (a type of white blood cell), and it carries a strong breed signature — Bernese Mountain Dogs, Flat-Coated Retrievers, Rottweilers, and Golden Retrievers are notably predisposed. It's a less common cancer, but a serious one, and because standard treatment has real limitations, it's an area where clinical trials can genuinely expand a family's options. Pet Trial Finder currently tracks 4 histiocytic sarcoma trials across accredited U.S. veterinary teaching hospitals. Here's what to know.
What Is Canine Histiocytic Sarcoma?
Histiocytic sarcoma arises from histiocytes and can appear as a single mass or as widespread disease. That distinction — localized versus disseminated — is the single most important factor in the outlook, and it shapes every treatment decision that follows.
You're on the right path 🐾
Ready to find your options?
The Forms of Histiocytic Sarcoma
Localized histiocytic sarcoma is a single tumor, often on a limb or in a joint, or in one organ; when it can be removed or irradiated before it spreads, this form offers the best chance at meaningful control. Disseminated histiocytic sarcoma (formerly called malignant histiocytosis) involves multiple sites at diagnosis — commonly the spleen, liver, lungs, and lymph nodes — and is the more aggressive presentation behind the disease's fearsome reputation. Hemophagocytic histiocytic sarcoma is a distinct, particularly aggressive form usually centered on the spleen, in which the malignant cells consume red blood cells and cause anemia; it carries the most guarded prognosis of all.
Standard Treatment and What It Costs
For localized disease, surgery and/or radiation control a single tumor — surgery at $1,500 to $4,000 or more, radiation at $4,000 to $8,000. CCNU (lomustine) chemotherapy is the backbone drug for histiocytic sarcoma, an oral chemotherapy that is the standard for disseminated disease and is often added after local treatment, at a relatively lower per-dose cost given in cycles with monitoring. Staging and specialist consultations run $200 to $500 per visit, plus imaging and bloodwork. The honest picture: localized histiocytic sarcoma treated aggressively before it spreads has the most favorable outlook, and some dogs do well for extended periods. Disseminated and hemophagocytic forms are far more difficult, with survival often measured in months even with chemotherapy. That gap between what standard care can offer and what families hope for is exactly why trials matter here.
Clinical Trials: What Is Being Studied
Targeted therapies are a rational and active area of study, because a meaningful subset of histiocytic sarcomas carry mutations in specific signaling pathways (such as the MAPK pathway) that make targeted drugs — including kinase and MEK inhibitors — a logical fit. CSF1R-directed approaches aim at a receptor central to histiocyte biology. Immunotherapy strategies seek to turn the immune system against this immune-cell cancer. And novel chemotherapy combinations build on CCNU to improve response and durability.
Who Qualifies for a Histiocytic Sarcoma Trial?
Most trials require a confirmed diagnosis (which can be challenging and sometimes needs specialized testing), staging to distinguish localized from disseminated disease, and adequate organ function. Some trials require molecular testing to identify a targetable mutation. Both dogs with localized disease and those with disseminated disease seeking additional options are commonly represented.
How Trial Costs Compare to Standard Treatment
Fully funded trials typically cover the investigational therapy, trial-specific diagnostics (sometimes including the molecular testing that identifies a target), and specialist monitoring — an offset against chemotherapy, radiation, and staging. Given how much room there is to improve on standard outcomes in the disseminated form, a trial may offer access to an approach that standard care simply can't. Pet Trial Finder checks your dog against all 4 active histiocytic sarcoma trials — plus the full database of 133 trials across 39 cancer types — in a single application. Results in hours, not weeks.